S&P Keeps Strong Buy on Citigroup

Analyst Mark Hebeka does not see any short-term impact of Magner's departure. Plus: opinions on Yahoo and Amylin Pharmaceuticals

Citigroup (C ): Reiterates 5 STARS (strong buy)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.